Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marc A. Boudreau is active.

Publication


Featured researches published by Marc A. Boudreau.


Proceedings of the Royal Society of London B: Biological Sciences | 2009

A new proposal concerning the botanical origin of Baltic amber

Alexander P. Wolfe; Ralf Tappert; Karlis Muehlenbachs; Marc A. Boudreau; Ryan C. McKellar; James F. Basinger; Amber Garrett

Baltic amber constitutes the largest known deposit of fossil plant resin and the richest repository of fossil insects of any age. Despite a remarkable legacy of archaeological, geochemical and palaeobiological investigation, the botanical origin of this exceptional resource remains controversial. Here, we use taxonomically explicit applications of solid-state Fourier-transform infrared (FTIR) microspectroscopy, coupled with multivariate clustering and palaeobotanical observations, to propose that conifers of the family Sciadopityaceae, closely allied to the sole extant representative, Sciadopitys verticillata, were involved in the genesis of Baltic amber. The fidelity of FTIR-based chemotaxonomic inferences is upheld by modern–fossil comparisons of resins from additional conifer families and genera (Cupressaceae: Metasequoia; Pinaceae: Pinus and Pseudolarix). Our conclusions challenge hypotheses advocating members of either of the families Araucariaceae or Pinaceae as the primary amber-producing trees and correlate favourably with the progressive demise of subtropical forest biomes from northern Europe as palaeotemperatures cooled following the Eocene climate optimum.


Journal of the American Chemical Society | 2014

Discovery of a New Class of Non-β-lactam Inhibitors of Penicillin-Binding Proteins with Gram-Positive Antibacterial Activity

Peter I. O’Daniel; Zhihong Peng; Hualiang Pi; Sebastian A. Testero; Derong Ding; Edward Spink; Erika Leemans; Marc A. Boudreau; Takao Yamaguchi; Valerie A. Schroeder; William R. Wolter; Leticia I. Llarrull; Wei Song; Elena Lastochkin; Malika Kumarasiri; Nuno T. Antunes; Mana Espahbodi; Katerina Lichtenwalter; Mark A. Suckow; Sergei B. Vakulenko; Shahriar Mobashery; Mayland Chang

Infections caused by hard-to-treat methicillin-resistant Staphylococcus aureus (MRSA) are a serious global public-health concern, as MRSA has become broadly resistant to many classes of antibiotics. We disclose herein the discovery of a new class of non-β-lactam antibiotics, the oxadiazoles, which inhibit penicillin-binding protein 2a (PBP2a) of MRSA. The oxadiazoles show bactericidal activity against vancomycin- and linezolid-resistant MRSA and other Gram-positive bacterial strains, in vivo efficacy in a mouse model of infection, and have 100% oral bioavailability.


Biochemistry | 2012

Messenger Functions of the Bacterial Cell Wall-derived Muropeptides

Marc A. Boudreau; Jed F. Fisher; Shahriar Mobashery

Bacterial muropeptides are soluble peptidoglycan structures central to recycling of the bacterial cell wall and messengers in diverse cell signaling events. Bacteria sense muropeptides as signals that antibiotics targeting cell-wall biosynthesis are present, and eukaryotes detect muropeptides during the innate immune response to bacterial infection. This review summarizes the roles of bacterial muropeptides as messengers, with a special emphasis on bacterial muropeptide structures and the relationship of structure to the biochemical events that the muropeptides elicit. Muropeptide sensing and recycling in both Gram-positive and Gram-negative bacteria are discussed, followed by muropeptide sensing by eukaryotes as a crucial event in the innate immune response of insects (via peptidoglycan-recognition proteins) and mammals (through Nod-like receptors) to bacterial invasion.


Journal of Medicinal Chemistry | 2015

Structure−Activity Relationship for the Oxadiazole Class of Antibiotics

Edward Spink; Derong Ding; Zhihong Peng; Marc A. Boudreau; Erika Leemans; Elena Lastochkin; Wei Song; Katerina Lichtenwalter; Peter I. O’Daniel; Sebastian A. Testero; Hualiang Pi; Valerie A. Schroeder; William R. Wolter; Nuno T. Antunes; Mark A. Suckow; Sergei B. Vakulenko; Mayland Chang; Shahriar Mobashery

The structure-activity relationship (SAR) for the newly discovered oxadiazole class of antibiotics is described with evaluation of 120 derivatives of the lead structure. This class of antibiotics was discovered by in silico docking and scoring against the crystal structure of a penicillin-binding protein. They impair cell-wall biosynthesis and exhibit activities against the Gram-positive bacterium Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA) and vancomycin-resistant and linezolid-resistant S. aureus. 5-(1H-Indol-5-yl)-3-(4-(4-(trifluoromethyl)phenoxy)phenyl)-1,2,4-oxadiazole (antibiotic 75b) was efficacious in a mouse model of MRSA infection, exhibiting a long half-life, a high volume of distribution, and low clearance. This antibiotic is bactericidal and is orally bioavailable in mice. This class of antibiotics holds great promise in recourse against infections by MRSA.


Journal of the American Chemical Society | 2010

Chemical Synthesis and Biological Activity of the Neopetrosiamides and Their Analogues: Revision of Disulfide Bond Connectivity

Hongqiang Liu; Marc A. Boudreau; Jing Zheng; Randy M. Whittal; Pamela Austin; Calvin D. Roskelley; Michel Roberge; Raymond J. Andersen; John C. Vederas

Neopetrosiamides A and B (2) from the marine sponge Neopetrosia sp. are two diastereomeric tricyclic peptides that inhibit tumor cell invasion associated with metastasis. The reported structures were chemically synthesized using solid-phase peptide synthesis and sequential stepwise disulfide bond formation in solution. The disulfide bond connectivity of the originally proposed structures was revised and confirmed by chemical synthesis together with a combination of HPLC analysis, disulfide mapping, and biological activity testing. This methodology was also utilized to generate analogues containing methionine or norleucine in place of the methionine sulfoxide at position 24. Compounds 4 and 6 demonstrated potent bioactivity comparable to that of the parent peptides.


Organic Letters | 2009

Retention of configuration in photolytic decarboxylation of peresters to form chiral acetals and ethers.

M. Daniel Spantulescu; Marc A. Boudreau; John C. Vederas

Peresters generate ethers in good yields when photolyzed in the absence of solvent using short wavelength UV light. At -78 degrees C or below, the process proceeds predominantly with retention of configuration at the site adjacent to the carbonyl where the decarboxylation occurs, but increase in temperature results in loss of stereochemical control. Chiral acyclic acetals can be prepared using precursors derived from tartaric or malic acids.


ACS Nano | 2016

Semisynthetic Nanoreactor for Reversible Single-Molecule Covalent Chemistry

Joongoo Lee; Arnold J. Boersma; Marc A. Boudreau; Stephen Cheley; Oliver Daltrop; Jianwei Li; Hiroko Tamagaki; Hagan Bayley

Protein engineering has been used to remodel pores for applications in biotechnology. For example, the heptameric α-hemolysin pore (αHL) has been engineered to form a nanoreactor to study covalent chemistry at the single-molecule level. Previous work has been confined largely to the chemistry of cysteine side chains or, in one instance, to an irreversible reaction of an unnatural amino acid side chain bearing a terminal alkyne. Here, we present four different αHL pores obtained by coupling either two or three fragments by native chemical ligation (NCL). The synthetic αHL monomers were folded and incorporated into heptameric pores. The functionality of the pores was validated by hemolysis assays and by single-channel current recording. By using NCL to introduce a ketone amino acid, the nanoreactor approach was extended to an investigation of reversible covalent chemistry on an unnatural side chain at the single-molecule level.


Bioorganic & Medicinal Chemistry Letters | 2016

Three-dimensional QSAR analysis and design of new 1,2,4-oxadiazole antibacterials.

Erika Leemans; Kiran V. Mahasenan; Malika Kumarasiri; Edward Spink; Derong Ding; Peter I. O’Daniel; Marc A. Boudreau; Elena Lastochkin; Sebastian A. Testero; Takao Yamaguchi; Mijoon Lee; Dusan Hesek; Jed F. Fisher; Mayland Chang; Shahriar Mobashery

The oxadiazole antibacterials, a class of newly discovered compounds that are active against Gram-positive bacteria, target bacterial cell-wall biosynthesis by inhibition of a family of essential enzymes, the penicillin-binding proteins. Ligand-based 3D-QSAR analyses by comparative molecular field analysis (CoMFA), comparative molecular shape indices analysis (CoMSIA) and Field-Based 3D-QSAR evaluated a series of 102 members of this class. This series included inactive compounds as well as compounds that were moderately to strongly antibacterial against Staphylococcus aureus. Multiple models were constructed using different types of energy minimization and charge calculations. CoMFA derived contour maps successfully defined favored and disfavored regions of the molecules in terms of steric and electrostatic properties for substitution.


Bioorganic & Medicinal Chemistry Letters | 2015

Exploration of the structure–activity relationship of 1,2,4-oxadiazole antibiotics

Derong Ding; Marc A. Boudreau; Erika Leemans; Edward Spink; Takao Yamaguchi; Sebastian A. Testero; Peter I. O’Daniel; Elena Lastochkin; Mayland Chang; Shahriar Mobashery

We have recently disclosed the discovery of the class of 1,2,4-oxadiazole antibiotics, which emerged from in silico docking and scoring efforts. This class of antibacterials exhibits Gram-positive activity, particularly against Staphylococcus aureus. We define the structure-activity relationship (SAR) of this class of antibiotics with the synthesis and evaluation of a series of 59 derivatives with variations in the C ring or C and D rings. A total of 17 compounds showed activity against S. aureus. Four derivatives were evaluated against a panel of 16 Gram-positive strains, inclusive of several methicillin-resistant S. aureus strains. These compounds are broadly active against Gram-positive bacteria.


ACS Infectious Diseases | 2015

Phosphorylation of BlaR1 in Manifestation of Antibiotic Resistance in Methicillin-Resistant Staphylococcus aureus and its Abrogation by Small Molecules

Marc A. Boudreau; Jennifer Fishovitz; Leticia I. Llarrull; Qiaobin Xiao; Shahriar Mobashery

Methicillin-resistant Staphylococcus aureus (MRSA), an important human pathogen, has evolved an inducible mechanism for resistance to β-lactam antibiotics. We report herein that the integral membrane protein BlaR1, the β-lactam sensor/signal transducer protein, is phosphorylated on exposure to β-lactam antibiotics. This event is critical to the onset of the induction of antibiotic resistance. Furthermore, we document that BlaR1 phosphorylation and the antibiotic-resistance phenotype are both reversed in the presence of synthetic protein kinase inhibitors of our design, restoring susceptibility of the organism to a penicillin, resurrecting it from obsolescence in treatment of these intransigent bacteria.

Collaboration


Dive into the Marc A. Boudreau's collaboration.

Top Co-Authors

Avatar

Shahriar Mobashery

University of Southern California

View shared research outputs
Top Co-Authors

Avatar

Derong Ding

University of Notre Dame

View shared research outputs
Top Co-Authors

Avatar

Edward Spink

University of Notre Dame

View shared research outputs
Top Co-Authors

Avatar

Erika Leemans

University of Notre Dame

View shared research outputs
Top Co-Authors

Avatar

Mayland Chang

University of Notre Dame

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hualiang Pi

University of Notre Dame

View shared research outputs
Researchain Logo
Decentralizing Knowledge